{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:24:18Z","timestamp":1792081458574,"version":"4.4.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["tmreviews.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Medicine Reviews"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.tmrv.2016.08.002","type":"journal-article","created":{"date-parts":[[2016,8,9]],"date-time":"2016-08-09T15:10:43Z","timestamp":1470755443000},"page":"217-222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Pediatric Therapeutic Apheresis: A Critical Appraisal of Evidence"],"prefix":"10.1016","volume":"30","author":[{"given":"Erin K.","family":"Meyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward C.C.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmrv.2016.08.002_bb0010","series-title":"Apheresis: principles and practice","first-page":"27","article-title":"Applications history","author":"Taft","year":"2010"},{"key":"10.1016\/j.tmrv.2016.08.002_bb0015","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.pcl.2013.08.006","article-title":"Pediatric therapeutic apheresis: rationale and indications for plasmapheresis, cytapheresis, extracorporeal photopheresis, and LDL apheresis","volume":"60","author":"Kim","year":"2013","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.tmrv.2016.08.002_bb0020","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/jca.21470","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice\u2014evidence-based approach from the Writing Committee of the American Society for Apheresis: the seventh special issue","volume":"31","author":"Schwartz","year":"2016","journal-title":"J Clin Apher"},{"key":"10.1016\/j.tmrv.2016.08.002_bb0025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/jca.2920050108","article-title":"Techniques, indications, and toxicity of therapeutic hemapheresis in children","volume":"5","author":"Kasprisin","year":"1989","journal-title":"J Clin Apher"},{"key":"10.1016\/j.tmrv.2016.08.002_bb0030","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1136\/adc.57.4.301","article-title":"Potential for plasma exchange in children","volume":"57","author":"Robinson","year":"1982","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.tmrv.2016.08.002_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1098-1101(1997)12:1<1::AID-JCA1>3.0.CO;2-E","article-title":"An overview of therapeutic apheresis in pediatrics","volume":"12","author":"Galacki","year":"1997","journal-title":"J Clin Apher"},{"key":"10.1016\/j.tmrv.2016.08.002_bb0040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0955-3886(99)00064-8","article-title":"Therapeutic plasma exchange and cytapheresis in pediatric patients","volume":"21","author":"Gorlin","year":"1999","journal-title":"Transfus Sci"},{"key":"10.1016\/j.tmrv.2016.08.002_bb0045","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/(SICI)1098-1101(2000)15:1\/2<129::AID-JCA7>3.0.CO;2-H","article-title":"Therapeutic pediatric apheresis","volume":"15","author":"Kim","year":"2000","journal-title":"J Clin Apher"},{"key":"10.1016\/j.tmrv.2016.08.002_bb0050","series-title":"Apheresis: principles and practice","first-page":"445","article-title":"Therapeutic apheresis in pediatric patients","author":"Kim","year":"2010"},{"key":"10.1016\/j.tmrv.2016.08.002_bb0055","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/jca.21263","article-title":"Randomized controlled trials in therapeutic apheresis","volume":"28","author":"Winters","year":"2013","journal-title":"J Clin Apher"},{"key":"10.1016\/j.tmrv.2016.08.002_bb0060","author":"Howick"},{"key":"10.1016\/j.tmrv.2016.08.002_bb0065","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/jca.21276","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice\u2014evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue","volume":"28","author":"Schwartz","year":"2013","journal-title":"J Clin Apher"},{"key":"10.1016\/j.tmrv.2016.08.002_bb0070","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1097\/CCM.0b013e318186aa49","article-title":"Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure","volume":"36","author":"Nguyen","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.tmrv.2016.08.002_bb0075","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1177\/08830738050200050601","article-title":"Treatment of Sydenham's chorea with intravenous immunoglobulin, plasma exchange, or prednisone","volume":"20","author":"Garvey","year":"2005","journal-title":"J Child Neurol"},{"key":"10.1016\/j.tmrv.2016.08.002_bb0080","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0140-6736(98)12297-3","article-title":"Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood","volume":"354","author":"Perlmutter","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.tmrv.2016.08.002_bb0085","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1053\/tmrv.2002.33433","article-title":"A review of randomized controlled trials using therapeutic apheresis","volume":"16","author":"Shehata","year":"2002","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tmrv.2016.08.002_bb0090","series-title":"Apheresis: principles and practice","first-page":"229","article-title":"Management of the therapeutic apheresis patient","author":"Chhibber","year":"2010"},{"key":"10.1016\/j.tmrv.2016.08.002_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jca.20184","article-title":"The Italian registry of pediatric therapeutic apheresis: a report on activity during 2005","volume":"24","author":"De Silvestro","year":"2009","journal-title":"J Clin Apher"},{"key":"10.1016\/j.tmrv.2016.08.002_bb0100","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1111\/j.1537-2995.2007.01405.x","article-title":"Complications of apheresis in children","volume":"47","author":"Michon","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2016.08.002_bb0105","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1473-0502(03)00121-6","article-title":"Therapeutic apheresis in Sweden: update of epidemiology and adverse events","volume":"29","author":"Norda","year":"2003","journal-title":"Transfus Apher Sci"},{"issue":"1","key":"10.1016\/j.tmrv.2016.08.002_bb0110","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1537-2995.2006.00687.x","article-title":"Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome","volume":"46","author":"Howard","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2016.08.002_bb0115","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1046\/j.1537-2995.2000.40080896.x","article-title":"Complications of plasma exchange in 71 consecutive patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic-uremic syndrome","volume":"40","author":"Rizvi","year":"2000","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2016.08.002_bb0120","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.transci.2008.09.001","article-title":"World apheresis registry data from 2003 to 2007, the pediatric and adolescent side of the registry","volume":"39","author":"Witt","year":"2008","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tmrv.2016.08.002_bb0125","first-page":"87","article-title":"Therapeutic apheresis in childhood","volume":"5","author":"Kevy","year":"1990","journal-title":"J Clin Apher"},{"key":"10.1016\/j.tmrv.2016.08.002_bb0130","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/jca.20129","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis","volume":"22","author":"Szczepiorkowski","year":"2007","journal-title":"J Clin Apher"},{"key":"10.1016\/j.tmrv.2016.08.002_bb0135","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jca.20240","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice\u2014evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis","volume":"25","author":"Szczepiorkowski","year":"2010","journal-title":"J Clin Apher"},{"key":"10.1016\/j.tmrv.2016.08.002_bb0140","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1002\/pbc.24612","article-title":"Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical features","volume":"60","author":"Reese","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.tmrv.2016.08.002_bb0145","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/humu.21143","article-title":"ADAMTS13 mutations and polymorphisms in congenital thrombotic thrombocytopenic purpura","volume":"31","author":"Lotta","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1016\/j.tmrv.2016.08.002_bb0150","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000184748","article-title":"The epidemiology of Guillain-Barre syndrome worldwide. A systematic literature review","volume":"32","author":"McGrogan","year":"2009","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.tmrv.2016.08.002_bb0155","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1212\/WNL.0b013e318207b1f6","article-title":"Evidence-based guideline update: plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology","volume":"76","author":"Cortese","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.tmrv.2016.08.002_bb0160","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/jnnp.52.7.853","article-title":"The natural history of the Guillain-Barre syndrome in 18 children and 50 adults","volume":"52","author":"Kleyweg","year":"1989","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.tmrv.2016.08.002_bb0165","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/ana.410280112","article-title":"The role of plasmapheresis in childhood Guillain-Barre syndrome","volume":"28","author":"Epstein","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1016\/j.tmrv.2016.08.002_bb0170","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/cc5064","article-title":"Bench-to-bedside review: thrombocytopenia-associated multiple organ failure\u2014a newly appreciated syndrome in the critically ill","volume":"10","author":"Nguyen","year":"2006","journal-title":"Crit Care"},{"key":"10.1016\/j.tmrv.2016.08.002_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1098-1101(2000)15:1\/2<1::AID-JCA1>3.0.CO;2-R","article-title":"Introduction to the third special issue: clinical applications of therapeutic apheresis","volume":"15","author":"McLeod","year":"2000","journal-title":"J Clin Apher"},{"key":"10.1016\/j.tmrv.2016.08.002_bb0180","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/jca.21242","article-title":"Pediatric therapeutic plasma exchange indications and patterns of use in US children's hospitals","volume":"27","author":"Weiss","year":"2012","journal-title":"J Clin Apher"},{"key":"10.1016\/j.tmrv.2016.08.002_bb0185","author":"National Heart Lung and Blood Institute"},{"key":"10.1016\/j.tmrv.2016.08.002_bb0190","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members","volume":"312","author":"Yawn","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.tmrv.2016.08.002_bb0195","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"23","author":"Schulz","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.tmrv.2016.08.002_bb0200","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.tmrv.2016.08.002_bb0205","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1378\/chest.129.1.174","article-title":"Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American College of Chest Physicians Task Force","volume":"129","author":"Guyatt","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.tmrv.2016.08.002_bb0210","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/jca.21301","article-title":"An international survey of pediatric apheresis practice","volume":"29","author":"Delaney","year":"2014","journal-title":"J Clin Apher"}],"container-title":["Transfusion Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796316300347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796316300347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,9]],"date-time":"2018-09-09T05:59:27Z","timestamp":1536472767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887796316300347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0887796316300347"],"URL":"https:\/\/doi.org\/10.1016\/j.tmrv.2016.08.002","relation":{},"ISSN":["0887-7963"],"issn-type":[{"value":"0887-7963","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pediatric Therapeutic Apheresis: A Critical Appraisal of Evidence","name":"articletitle","label":"Article Title"},{"value":"Transfusion Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmrv.2016.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}